Samsara BioCapital’s Gossamer Bio GOSS Stock Holding History

Samsara BioCapital’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Hold	7,222,559	–	–	0.23%	22
2025 Q4	$22.4M	Buy	7,222,559 +1,092,291	+18%	+$3.12M	2.31%	8
2025 Q3	$16.1M	Hold	6,130,268	–	–	2.11%	8
2025 Q2	$7.54M	Hold	6,130,268	–	–	1.54%	11
2025 Q1	$6.74M	Hold	6,130,268	–	–	1.2%	16
2024 Q4	$5.55M	Hold	6,130,268	–	–	0.76%	22
2024 Q3	$6.05M	Hold	6,130,268	–	–	1.16%	20
2024 Q2	$5.52M	Hold	6,130,268	–	–	1.16%	20
2024 Q1	$7.23M	Hold	6,130,268	–	–	1.12%	19
2023 Q4	$5.59M	Hold	6,130,268	–	–	0.87%	22
2023 Q3	$5.11M	Buy	+6,130,268	New	+$7.06M	1.56%	18
2019 Q4	–	Sell	-376,583	Closed	-$6.32M	–	20
2019 Q3	$6.32M	Hold	376,583	–	–	4.3%	9
2019 Q2	$8.35M	Sell	376,583 -156,337	-29%	-$2.99M	5.52%	8
2019 Q1	$11.5M	Buy	+532,920	New	+$11.1M	9.08%	6

Other funds holding GOSS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Samsara BioCapital's GOSS Position: Q1 2026 in Review

Samsara BioCapital held its Gossamer Bio (GOSS) position steady in Q1 2026 at 7,222,559 shares worth $2.37M. The position accounts for 0.23% of the portfolio, ranked #22.

Samsara BioCapital first reported a position in GOSS in Q1 2019 and has held it in 14 quarters since. The position peaked at $22.4M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

Samsara BioCapital held 7,222,559 shares of Gossamer Bio worth $2.37M as of Q1 2026.
Samsara BioCapital left its Gossamer Bio share count unchanged in Q1 2026.
Gossamer Bio made up 0.23% of Samsara BioCapital's portfolio in Q1 2026, its #22 holding.
Samsara BioCapital first reported a position in Gossamer Bio in Q1 2019 and has held it in 14 quarters since.
Samsara BioCapital's Gossamer Bio position peaked at $22.4M in Q4 2025.
184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Samsara BioCapital's 13F filing for Q1 2026, filed 15 May 2026.